Holen Sie sich die Stockscreener-App
29.76
4.03%
-1.25
Vorhandelsmarkt:
29.93
0.17
+0.57%
Schlusskurs vom Vortag:
$31.01
Offen:
$30.72
24-Stunden-Volumen:
742.47K
Relative Volume:
1.21
Marktkapitalisierung:
$1.39B
Einnahmen:
$1.08B
Nettoeinkommen (Verlust:
$-20.76M
KGV:
-64.70
EPS:
-0.46
Netto-Cashflow:
$151.63M
1W Leistung:
+5.27%
1M Leistung:
-0.57%
6M Leistung:
-33.85%
1J Leistung:
-23.40%
1-Tages-Spanne:
$29.51
$30.89
1-Wochen-Bereich:
$28.09
$33.99
52-Wochen-Spanne:
$22.66
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Firmenname
Omnicell Inc
Sektor
Branche
Telefon
(877) 415-9990
Adresse
4220 NORTH FREEWAY, FORT WORTH
Vergleichen Sie OMCL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
29.76 | 1.45B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
281.35 | 46.44B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
54.89 | 9.80B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
91.06 | 8.39B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
57.33 | 11.01B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.59 | 6.44B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-14 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-02 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Eingeleitet | Barclays | Underweight |
| 2023-11-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Bestätigt | Wells Fargo | Underweight |
| 2023-08-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Eingeleitet | BofA Securities | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-12-06 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-09 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-24 | Eingeleitet | BTIG Research | Buy |
| 2021-02-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-12-03 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-02-07 | Bestätigt | Dougherty & Company | Buy |
| 2019-11-21 | Bestätigt | Dougherty & Company | Buy |
| 2019-07-26 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-03-07 | Bestätigt | Dougherty & Company | Buy |
| 2018-06-29 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-09-05 | Bestätigt | The Benchmark Company | Buy |
| 2017-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2017-04-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Eingeleitet | Dougherty & Company | Buy |
| 2016-12-06 | Bestätigt | The Benchmark Company | Buy |
| 2016-07-07 | Bestätigt | FBR Capital | Outperform |
| 2016-03-21 | Bestätigt | Topeka Capital Markets | Buy |
| 2016-01-07 | Eingeleitet | The Benchmark Company | Buy |
| 2015-11-16 | Bestätigt | Topeka Capital Markets | Buy |
| 2015-10-30 | Bestätigt | FBR Capital | Outperform |
| 2015-09-28 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-07-31 | Bestätigt | Topeka Capital Markets | Buy |
Alle ansehen
Omnicell Inc Aktie (OMCL) Neueste Nachrichten
What is Omnicell Inc. company’s growth strategyMaximize gains with proven stock analysis - jammulinksnews.com
What analysts say about Omnicell Inc. stockMassive profits - jammulinksnews.com
Omnicell Inc. Stock Analysis and ForecastInvest smarter with actionable market insights - jammulinksnews.com
What are the latest earnings results for Omnicell Inc.Get insider insights into market trends - jammulinksnews.com
Is Omnicell Inc. a growth stock or a value stockAchieve consistent profits with expert strategies - jammulinksnews.com
When is Omnicell Inc. stock expected to show significant growthBuild a portfolio for long-term financial success - jammulinksnews.com
Is it the right time to buy Omnicell Inc. stockInvest smarter with actionable trading signals - jammulinksnews.com
How does Omnicell Inc. compare to its industry peersDouble-digit growth - jammulinksnews.com
Why is Omnicell Inc. stock attracting strong analyst attentionTremendous return rates - jammulinksnews.com
What is the dividend policy of Omnicell Inc. stockCapitalize on emerging investment opportunities - jammulinksnews.com
What markets is SEAL.PRB expanding into Is Omnicell Inc. stock a good long term investment optionAchieve consistent high returns with low risk - jammulinksnews.com
How strong is Omnicell Inc. company’s balance sheetExceptional financial outcomes - jammulinksnews.com
Omnicell's Q2 2025 Earnings Highlight Resilience and Growth in Healthcare Automation - AInvest
Omnicell's Q2 2025 Earnings Outperformance: A Strategic Case for Capitalizing on a Resilient Medical Tech Innovator - AInvest
Omnicell Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Omnicell's Financial Performance and Growth Prospects Support Buy Rating - AInvest
Omnicell's Strategic Shift to Recurring Revenue: A Pathway to Sustainable Growth in 2025 - AInvest
Omnicell's Q2 2025 Earnings and Strategic Edge in the Autonomous Pharmacy Market: A Case for Long-Term Growth - AInvest
Omnicell, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:OMCL) - Seeking Alpha
Pharmacy Automation Market: Strategic Growth, Competitive Landscape & Long-Term Value for Healthcare Leaders - Barchart.com
What are analysts’ price targets for Omnicell Inc. in the next 12 monthsExpert Picks Outlook From AI Tools - jammulinksnews.com
Wall Street Analysts See a 44.47% Upside in Omnicell (OMCL): Can the Stock Really Move This High? - Yahoo Finance
Omnicell outlines $40M tariff impact and anticipates $1.105B-$1.155B revenue for 2025 - MSN
Omnicell: Q2 Earnings Snapshot - Norwalk Hour
PSI Software Q2 2025 Earnings: €0.11 loss per share, up 73% from Q2 2024; revenue increases 18% to €73.0m. - AInvest
Omnicell Raises Guidance After Outpacing Analyst Expectations - Finimize
Omnicell Q2 Earnings: Market Ignoring The Segments (NASDAQ:OMCL) - Seeking Alpha
Earnings call transcript: Omnicell Q2 2025 beats expectations with strong earnings By Investing.com - Investing.com South Africa
Earnings call transcript: Omnicell Q2 2025 beats expectations with strong earnings - Investing.com
Omnicell Shares Marginally Higher After Reporting Fall in Q2 Earnings, Higher Revenue - 富途牛牛
Omnicell Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Omnicell Shares Climb Over 2% After Second Quarter Results Surpass Expectations - MSN
Omnicell Q2 2025 slides: Revenue up 5%, shares jump on recurring revenue growth - Investing.com Australia
Omnicell Q2 2025 slides: Revenue up 5%, shares jump on recurring revenue growth By Investing.com - Investing.com South Africa
Omnicell's Strategic Momentum and Earnings Outperformance: A Case for Upside in Automated Healthcare Solutions - AInvest
Omnicell (OMCL) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Omnicell Announces Second Quarter 2025 Results | OMCL Stock News - GuruFocus
Omnicell shares rise over 2% as second quarter results exceed expectations - Investing.com Nigeria
Omnicell (NASDAQ:OMCL) Reports Upbeat Q2, Full-Year Outlook Slightly Exceeds Expectations - Yahoo Finance
OMNICELL Earnings Results: $OMCL Reports Quarterly Earnings - Quiver Quantitative
Omnicell Announces Strong Q2 2025 Financial Results - TradingView
Omnicell Announces Second Quarter 2025 Results - Yahoo Finance
Intrinsic Value of Omnicell Inc. Stock: Is It Undervalued or OvervaluedQuick Gain Stock Watch With Indicators Reviewed - beatles.ru
Finanzdaten der Omnicell Inc-Aktie (OMCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Omnicell Inc-Aktie (OMCL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| PARRISH MARK W | Director |
Dec 10 '24 |
Sale |
47.30 |
12,000 |
567,638 |
58,427 |
0.98%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):